Catalog Peptides Market Share, Size, Future Demand, and Emerging Trends

Considering the continued R&D on the subject, P&S Intelligence forecasts that the catalog peptides market will grow from $238.4 million in 2018 to $332.1 million by 2024, at a 5.8% CAGR between 2019 and 2024 (forecast period).
CALABASAS, Calif. - April 13, 2022 - PRLog -- The body is made up of bones, muscles, tendons, cartilage, and blood, all of which are, in turn, made of tissues. The tissues are further made of cells, which are ultimately made of proteins and peptides. Therefore, be it disease diagnosis and treatment, nutrition, or even anti-aging and skincare, peptides have wide-ranging applications in healthcare, many of which people still don't know about. Hence, research and development (R&D) on these molecules is extensive, already shedding light on around 700 individual peptides occurring naturally!

Apart from drug development, peptides are important in antibody production, enzyme profiling, disease research, biomarker discovery, and therapeutics. Presently, drug development, antibody production, and enzyme profiling, which together make up the commercial applications, account for the highest production and consumption of peptides. Apart from pharmaceuticals, they are also used in cosmetics. For instance, collagen and elastin are widely used to make aging skin bulkier and fuller, while antimicrobial peptides are being used for melanin production and skin whitening.

This is also why among all the entities that produce and consume peptides, including contract manufacturing organizations (CMOs) and contract research organizations (CROs), pharmaceutical and biotechnology companies, and academic and research institutes, pharma and biotech companies are the most significant. With the growing prevalence of all types of diseases, the demand for peptide-based therapeutics is rising. For instance, collagen is not only used for skincare, but also in advanced wound care, in the form of collagen-based biologics and collagen dressing. Similarly, recent research on the GLP-1 peptide has signaled that it could be more effective in diabetes treatment since it can change its shape inside the body.

Due to such extensive R&D in this field, North America dominated the catalog peptides market ( during the historical period (2014–2018). Moreover, many large pharmaceutical and biotechnology companies are operational in the region, which not only results in a large number of research projects, but also high-volume peptide production and consumption. Further, the region accounts for a high prevalence of cancer, CVDs, MS, and diabetes, which drives the demand for peptide-based drugs.

Thus, with a better understanding of peptides and their functions inside the human body, the demand for them in disease diagnosis and treatment will boom.

Pramod Kumar
Email:*** Email Verified
Tags:Catalog Peptides Market
Location:Calabasas - California - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
P&S Intelligence News
Most Viewed
Daily News

Like PRLog?
Click to Share